Bank of New York Mellon’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-551,745
| Closed | -$51.3M | – | 4737 |
|
|
2021
Q4 | $51.3M | Sell |
551,745
-405,953
| -42% | -$26.7M | 0.01% | 1140 |
|
|
2021
Q3 | $57M | Buy |
957,698
+8,332
| +0.9% | +$492K | 0.01% | 1047 |
|
|
2021
Q2 | $64.7M | Buy |
949,366
+11,775
| +1% | +$768K | 0.01% | 975 |
|
|
2021
Q1 | $65.1M | Buy |
937,591
+33,630
| +4% | +$2.59M | 0.01% | 936 |
|
|
2020
Q4 | $69.5M | Buy |
903,961
+128,708
| +17% | +$9.65M | 0.02% | 836 |
|
|
2020
Q3 | $58M | Sell |
775,253
-1,067
| -0.1% | -$71.1K | 0.01% | 834 |
|
|
2020
Q2 | $48.9M | Buy |
776,320
+344,497
| +80% | +$19M | 0.01% | 891 |
|
|
2020
Q1 | $18.1M | Buy |
431,823
+208,037
| +93% | +$9.54M | 0.01% | 1350 |
|
|
2019
Q4 | $10.2M | Buy |
223,786
+8,199
| +4% | +$388K | ﹤0.01% | 1962 |
|
|
2019
Q3 | $9.87M | Sell |
215,587
-13,720
| -6% | -$771K | ﹤0.01% | 1948 |
|
|
2019
Q2 | $13.4M | Buy |
229,307
+12,961
| +6% | +$670K | ﹤0.01% | 1788 |
|
|
2019
Q1 | $9.7M | Sell |
216,346
-38,080
| -15% | -$1.75M | ﹤0.01% | 1990 |
|
|
2018
Q4 | $9.91M | Buy |
254,426
+35,756
| +16% | +$1.4M | ﹤0.01% | 1902 |
|
|
2018
Q3 | $10.1M | Sell |
218,670
-24,337
| -10% | -$987K | ﹤0.01% | 2022 |
|
|
2018
Q2 | $10.6M | Buy |
243,007
+17,541
| +8% | +$754K | ﹤0.01% | 1992 |
|
|
2018
Q1 | $8.9M | Buy |
225,466
+56,929
| +34% | +$2.21M | ﹤0.01% | 2036 |
|
|
2017
Q4 | $5.72M | Sell |
168,537
-1,799
| -1% | -$51.2K | ﹤0.01% | 2291 |
|
|
2017
Q3 | $4.34M | Buy |
170,336
+30,660
| +22% | +$703K | ﹤0.01% | 2405 |
|
|
2017
Q2 | $2.36M | Buy |
139,676
+21,486
| +18% | +$295K | ﹤0.01% | 2762 |
|
|
2017
Q1 | $1.73M | Buy |
118,190
+1,045
| +0.9% | +$15.5K | ﹤0.01% | 2935 |
|
|
2016
Q4 | $1.66M | Buy |
117,145
+4,180
| +4% | +$64.7K | ﹤0.01% | 2960 |
|
|
2016
Q3 | $1.98M | Sell |
112,965
-1,214
| -1% | -$20.1K | ﹤0.01% | 2771 |
|
|
2016
Q2 | $1.95M | Buy |
114,179
+768
| +0.7% | +$13.7K | ﹤0.01% | 2720 |
|
|
2016
Q1 | $2.23M | Buy |
113,411
+272
| +0.2% | +$4.36K | ﹤0.01% | 2589 |
|
|
2015
Q4 | $2.15M | Sell |
113,139
-1,531
| -1% | -$31.2K | ﹤0.01% | 2672 |
|
|
2015
Q3 | $2.19M | Sell |
114,670
-28,449
| -20% | -$966K | ﹤0.01% | 2680 |
|
|
2015
Q2 | $6.64M | Buy |
143,119
+10,121
| +8% | +$439K | ﹤0.01% | 2183 |
|
|
2015
Q1 | $5.81M | Buy |
132,998
+14,471
| +12% | +$673K | ﹤0.01% | 2233 |
|
|
2014
Q4 | $4.11M | Sell |
118,527
-4,256
| -3% | -$173K | ﹤0.01% | 2420 |
|
|
2014
Q3 | $5.14M | Sell |
122,783
-2,836
| -2% | -$127K | ﹤0.01% | 2303 |
|
|
2014
Q2 | $7.36M | Buy |
125,619
+352
| +0.3% | +$22.2K | ﹤0.01% | 2106 |
|
|
2014
Q1 | $7.89M | Buy |
125,267
+546
| +0.4% | +$36.2K | ﹤0.01% | 2055 |
|
|
2013
Q4 | $7.3M | Sell |
124,721
-612
| -0.5% | -$32K | ﹤0.01% | 2066 |
|
|
2013
Q3 | $6.61M | Buy |
125,333
+4,296
| +4% | +$288K | ﹤0.01% | 2059 |
|
|
2013
Q2 | $9.32M | Buy |
+121,037
| New | +$9.88M | ﹤0.01% | 1822 |
|
Bank of New York Mellon's ARNA Position: Q1 2022 in Review
Bank of New York Mellon sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 551,745 shares — an estimated $51.3M sold.
Bank of New York Mellon first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $69.5M in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Bank of New York Mellon reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Bank of New York Mellon sold 551,745 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $51.3M.
- Bank of New York Mellon first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
- Bank of New York Mellon's Arena Pharmaceuticals Inc position peaked at $69.5M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Bank of New York Mellon's 13F filing for Q1 2022, filed 11 May 2022.